• In late May 2026, CoreWeave announced it had become the first AI cloud provider to stand up, fully validate, and operate NVIDIA’s Vera Rubin NVL72 rack-scale system on its cloud, integrating custom liquid cooling, rack control, and networking to unlock the platform’s advanced agentic AI capabilities.
• An interesting angle is that this Vera Rubin deployment relies on CoreWeave-built software-defined cooling and unified rack management, effectively turning each NVIDIA rack into a standardized cloud resource rather than a bespoke hardware project.
• Next, we’ll examine how CoreWeave’s exclusive early deployment of NVIDIA’s Vera Rubin NVL72 could influence the company’s long-term AI infrastructure investment narrative.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

CoreWeave Investment Narrative Recap

To own CoreWeave, you need to believe AI infrastructure remains capacity constrained and that a specialized provider can turn early access to NVIDIA’s newest systems into durable, contracted demand. The Vera Rubin NVL72 launch reinforces CoreWeave’s positioning around cutting edge hardware and could support the key short term catalyst of converting backlog into live, billable workloads, while the biggest near term risk remains the company’s heavy capital needs and interest burden as it races to bring new capacity online.

Among recent developments, the expanded AI cloud capacity agreement with Meta through 2032, at about US$21,000,000,000, is particularly relevant here. That deal ties long dated customer commitments to the kind of high end infrastructure Vera Rubin represents, potentially supporting utilization of new racks once deployed. At the same time, it also underscores the stakes of CoreWeave’s execution risk: large, power hungry contracts sitting on top of rising debt and ongoing data center build out.

Yet behind the excitement around Vera Rubin, investors should also be aware of rising debt levels and interest costs that could...

CoreWeave's narrative projects $26.9 billion revenue and $1.6 billion earnings by 2028. This requires 84.2% yearly revenue growth and roughly a $2.4 billion earnings increase from -$824.7 million today.

Uncover how CoreWeave's forecasts yield a $133.12 fair value, a 12% upside to its current price.

Exploring Other Perspectives

Before this Vera Rubin milestone, the most optimistic analysts were already modeling revenue of about US$37,600,000,000 and US$3,600,000,000 of earnings by 2028, which is far more upbeat than the consensus view and could look either more achievable or more fragile once CoreWeave’s new capacity, debt load and execution risks are reassessed in light of the latest news.

Explore 67 other fair value estimates on CoreWeave - why the stock might be worth over 5x more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your CoreWeave research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free CoreWeave research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CoreWeave's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Our top stock finds are flying under the radar-for now. Get in early:

• We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Rare earth metals are the new gold rush. Find out which 32 stocks are leading the charge.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.